Navigate to Other Instruments
PMPhilip Morris International Inc
Philip Morris International Inc
PMHow can you trade Philip Morris International Inc? Philip Morris International Inc (PM) is publicly listed. On CoinUnited, eligible users can trade a PM stock CFD — price exposure that tracks the share price. It is a price CFD, not equity (no shareholder voting; dividends reflected as an adjustment) — with extended / 24-hour trading and leverage, from US$100. Access terms vary by jurisdiction and product eligibility.
Key facts & how to trade
Access & Tradability Comparison
A CoinUnited stock CFD vs holding the underlying shares — how, when, and in what form you get exposure. The stock price is everywhere; this comparison is the differentiator.
| Terms | CoinUnited (CFD) | Holding shares (exchange) |
|---|---|---|
| Product form | Stock CFD (price exposure) | Equity ownership |
| Trading hours | Extended / 24h (by product) | Exchange regular hours |
| Leverage | Available (by product terms) | None / margin account needed |
| Shareholder rights | None (no voting; dividends as adjustment) | Voting + dividends |
| Access | Eligible users, by region + product | Brokerage account required |
*Access and minimum vary by jurisdiction and product eligibility.
Key Facts
The most-cited facts about this company, each with its source — the quick-reference box for readers and AI answer engines.
Primary source: Wikidata
| Founded | 2008 |
|---|---|
| Headquarters | Lausanne, Stamford |
| CEO | Hamish Maxwell |
| Industry | tobacco industry, fast-moving consumer goods |
| Listing status | Publicly listed: PMExchange |
| Market cap | $293B (as of 2026-08-23)CoinUnited reference x SEC shares |
| P/E | ~25.9CoinUnited reference / SEC annual EPS |
| 52-week range | $142.16 – $207.72CoinUnited daily kline |
| Next earnings | 2026-10-21Finnhub |
| CoinUnited product | Stock CFD — price exposure, not equity (no voting; dividends reflected as adjustment); leverage available, extended/24hCoinUnited product terms |
Price & Market Structure
Company & financials
What Is Philip Morris International Inc (PM)?
TL;DR
Philip Morris International is a large-cap consumer staples company executing a structural transition from combustible tobacco toward smoke-free nicotine products, with Q2 2026 revenues surpassing $11 billion for the first time.
Philip Morris International (ticker: PM) is a multinational tobacco and nicotine company that manufactures and markets cigarettes, heated tobacco units, and e-vapor products across international markets.
Business Segments and Revenue Structure
The first two are the primary revenue engines.
| Segment | Q2 2026 Net Revenue | YoY Growth | Organic Growth |
|---|---|---|---|
| International Smoke-Free | ~$3.88 billion | +14.2% | +11.8% |
| International Combustibles | ~$6.46 billion | +9.8% | +6.4% |
| U.S. | ~$856 million | -0.7% | -0.9% |
Total Q2 2026 net revenues reached approximately $11.2 billion, up 10.4% year over year with organic growth of 7.6%, the first time the company has surpassed $11 billion in a single quarter. Smoke-free products accounted for roughly 42% of total net revenues in that quarter, reflecting the ongoing structural shift in the revenue mix.
Strategic Identity: The Smoke-Free Transition
PM's most consequential strategic development is its deliberate pivot away from combustible cigarettes toward reduced-risk nicotine products, principally its IQOS heated tobacco platform.
The International Combustibles segment held a margin of 67.9%, up 1.0 percentage point. These margin profiles highlight that the transition is not dilutive to profitability, smoke-free products are accretive at the gross level.
The U.S. segment, which includes brands such as IQOS and ZYN nicotine pouches following PM's acquisition of Swedish Match, remains a smaller and currently declining contributor. Its strategic role is long-term market development rather than near-term revenue leadership.
Sector Classification and Business Model Characteristics
PM is classified in the Consumer Staples sector. Its products exhibit inelastic demand, purchase frequency is largely insensitive to moderate price increases, and carry strong brand equity across multiple geographies. These characteristics generate predictable, recurring cash flows that support the company's dividend-oriented capital return posture.
The business model is not growth-oriented in the conventional sense; the investment thesis has historically centered on yield, pricing power, and now the pace of smoke-free volume conversion.
PM's Q2 2026 results also fit within the broader pattern of large-cap consumer and industrial companies posting solid earnings in the period, a trend tracked in the Q2 Earnings Beat Blue-Chip Surge theme. For broader equity market context, the 2026 Stocks Market Outlook provides relevant macro framing.
Trading PM as a CFD on CoinUnited
On CoinUnited, PM is available as a CFD position, price exposure that tracks the underlying equity without conferring shares, voting rights, or dividend entitlements. The platform charges zero trading fees, operates 24/7 without exchange session limits or market holidays, and accepts crypto for funding with no bank account required. The PM CFD carries a maximum leverage of 800x.
A trader opening a $50 position at 200x leverage controls $10,000 of notional exposure; a move of 1% in the underlying price produces a $100 gain or loss on that position, approximately 200% of the initial margin. Position sizing relative to leverage is the critical variable to manage.
Last updated: 2026-08-16
Key Insights
- Smoke-free products represented approximately 42% of PM's total net revenues in Q2 2026, with that segment growing at roughly double the rate of the legacy combustibles business, the revenue mix shift is the primary long-term structural story.
- Adjusted diluted EPS of $2.20 in Q2 2026 beat consensus estimates and grew roughly 15% year over year, demonstrating that the smoke-free transition is accretive to earnings, not merely a revenue offset.
- The International Smoke-Free segment carries an adjusted gross profit margin of 70.1%, exceeding the combustibles margin of 67.9%, which implies that successful smoke-free scaling should structurally expand overall company margins over time.
- PM's U.S. segment remains a drag, with Q2 2026 revenues declining organically and adjusted operating income falling sharply, U.S. execution risk is a key differentiated factor from purely international tobacco peers.
- At a 10-year Treasury yield of 4.63%, the rate environment compresses the relative appeal of dividend-heavy staples names; PM's equity risk premium must be assessed against this elevated risk-free rate backdrop.
Key Financials
Audited · SEC filingsReported figures from the company’s latest SEC filings — each linked to its source filing and period.
Quarterly revenue
~ Q4 is not filed as a standalone quarter — it is the annual 10-K figure minus the three filed quarters.
Figures are from the company’s audited SEC filings; each carries its filing source and period. Not investment advice.
PM's Competitive Position in Global Tobacco and Nicotine
Philip Morris International competes primarily against British American Tobacco (BAT) and Japan Tobacco International in international markets. A foundational distinction separates PM from its closest U.S.-listed peer, Altria: PM has no primary U.S. cigarette business.
Its international combustibles and smoke-free operations generate the overwhelming majority of revenues, insulating the company from the specific regulatory and litigation dynamics that define the U.S. cigarette market. The U.S. segment, covering smoke-free and oral nicotine products, contributed roughly $856 million in Q2 2026 net revenues, a fraction of the total $11.2 billion.
IQOS and the Structural Case for Market Leadership
The IQOS heated tobacco platform is PM's primary competitive differentiator.
The divergence confirms that smoke-free momentum is not a pricing artifact; volume is expanding alongside revenue, a structural advantage over combustibles-only peers whose revenue management depends almost entirely on price increases applied to a shrinking base.
For context on how PM's results fit within the broader pattern of large-cap consumer companies, traders tracking sector-level earnings dynamics can refer to the Consumer, Industrial & Energy Earnings Beat theme.
Margin Profile: Smoke-Free as the Higher-Quality Segment
The margin comparison between PM's two core international segments is instructive:
| Segment | Q2 2026 Adj. Gross Profit Margin | YoY Change |
|---|---|---|
| International Smoke-Free | 70.1% | +1.8 pp |
| International Combustibles | 67.9% | +1.0 pp |
The smoke-free segment already carries a higher adjusted gross profit margin than combustibles, and that gap widened year over year. For BAT and other peers whose non-combustible portfolios have historically carried dilutive margins relative to cigarettes, PM's ability to generate a premium margin in its growth segment represents a meaningful structural distinction.
Direct quarterly peer comparisons require independent verification, but the directional advantage is visible within PM's own reporting.
Positioning Within Consumer Staples
Within the Consumer Staples sector, PM's profile is differentiated by double-digit smoke-free segment growth running alongside stable combustibles cash generation.
Consumer Staples stocks are generally prized for earnings reliability, and PM's smoke-free transition adds a volume-growth dimension that most sector peers, whose revenues depend on pricing alone, do not offer.
Traders monitoring PM as part of a broader blue-chip earnings thesis may find additional context in the Q2 Earnings Beat Blue-Chip Surge theme, which tracks large-cap outperformance patterns across reporting seasons.
The competitive moat rests on three pillars: the entrenched global scale of the IQOS ecosystem and its consumables lock-in, a smoke-free margin profile that is accretive rather than dilutive, and a revenue base diversified across international geographies that reduces concentration risk relative to single-market operators.
Why Trade PM? Key Drivers, Catalysts, and Risks
Philip Morris International presents a structured analytical case built around an ongoing business-model transition, near-term earnings momentum, and a set of macro and operational risks that are material for leveraged CFD traders to assess before entering a position.
The Bull Case: Smoke-Free Transition as a Margin-Accretive Growth Engine
The core structural argument for PM rests on a premise that is now visible in reported financials: smoke-free products are growing faster than legacy combustibles and doing so at higher margins.
Its adjusted gross profit margin reached 70.1%, compared to 67.9% for International Combustibles. This spread matters because it invalidates the common concern that transitioning away from cigarettes would compress company-level profitability. Smoke-free products already account for roughly 42% of total net revenues, and that share is rising.
The implication for traders: if smoke-free volume continues converting at its current pace, PM's blended margin profile should improve over time without requiring combustibles volume growth. This is a relatively durable structural thesis, less sensitive to a single quarter's macro conditions than many growth-sector names.
Near-Term Catalyst: Earnings Momentum
PM's track record of earnings beats fits within the broader Q2 Earnings Beat Blue-Chip Surge pattern visible across large-cap consumer companies in mid-2026.
Positive EPS surprises of this magnitude have historically generated price reactions in the session following publication. For CFD traders focused on event-driven setups, earnings dates are a key period of elevated activity and wider potential range.
Total Q2 2026 net revenues of approximately $11.2 billion grew 10.4% year over year, with organic growth of 7.6%.
Currency Risk: A Structural Variable Independent of Operations
PM derives the large majority of its revenues from non-U.S. markets, making foreign exchange a persistent factor in reported results. This gap can reverse.
When the U.S. dollar strengthens broadly, reported revenues, earnings, and guidance can fall short of expectations even when underlying operations perform well. Traders should treat reported and organic figures as distinct data points and monitor dollar-index direction as a secondary input to PM-specific analysis.
U.S. Segment: An Active Risk Factor
The U.S. segment reported Q2 2026 organic revenue decline of 0.9%, with adjusted operating income falling 50.2% organically to approximately $379 million. A non-cash impairment charge on the RBH equity investment contributed to the GAAP diluted EPS of $1.80, down 7.7% year over year, creating a notable divergence from the adjusted figure.
The U.S. business requires separate monitoring from the international operations; a deterioration in ZYN or IQOS U.S. performance carries implications for long-term growth expectations that the international segment alone cannot offset.
Macro Rate Sensitivity
High-yield consumer staples equities are structurally sensitive to the risk-free rate: when Treasury yields rise, the relative attractiveness of dividend income compresses, and the earnings multiples applied to stable-cash-flow businesses face downward pressure.
PM's dividend yield and valuation must be continuously reassessed in the context of the prevailing rate environment. The Fed Hold vs. Rate Hike Risk dynamic remains a live variable for any rate-sensitive equity position.
Risk Summary Table
| Risk Factor | Nature | Monitoring Signal |
|---|---|---|
| Currency fluctuation | Structural, recurring | USD index direction, FX guidance |
| U.S. segment weakness | Operational, segment-specific | Quarterly organic revenue/OI trends |
| Rate environment | Macro, valuation-linked | U.S. 10-year Treasury yield |
| GAAP vs. adjusted divergence | Accounting, event-driven | Non-cash charges, impairments |
| Regulatory shifts | Policy, multi-jurisdiction | Heated tobacco and nicotine pouch rules |
Traders should weigh these factors as independent variables. A strong international smoke-free quarter can coexist with a U.S. impairment charge and a currency headwind in the same reporting period, all three require separate analysis.
Valuation & peers
Peer Valuation Comparison
How this stock trades versus comparable listed companies on trailing valuation multiples.
| Company | Market cap | P/E | P/S |
|---|---|---|---|
| Philip Morris International Inc · PM | $293.4B | 27.0x | 6.9x |
| The Coca-Cola Company · KO | $392.0B | 27.4x | 7.8x |
| The Procter & Gamble Company · PG | $343.9B | 21.4x | 4.0x |
| PepsiCo, Inc. · PEP | $196.0B | 18.8x | 2.0x |
| Anheuser-Busch InBev SA/NV · BUD | $155.4B | 13.2x | 2.0x |
| Unilever PLC · UL | $138.2B | 21.2x | 2.6x |
Third-party ratios (FMP), trailing twelve months. Multiples vary by data window; a negative or absent P/E means the company is loss-making. Not investment advice.
Analyst Price Targets
BuyWall Street sell-side analysts’ consensus 12-month price target and rating for this stock.
Targets by firm
Latest target from each of the 6 firms whose call was reported in the past 180 days. Each row links to the report.
| Firm | Target | vs current |
|---|---|---|
| Barclays2026-07-29 · TheFly | $225.00 | +19.5% |
| BTIG2026-07-24 · TheFly | $221.00 | +17.4% |
| Stifel Nicolaus2026-07-23 · TheFly | $205.00 | +8.9% |
| Needham2026-07-23 · StreetInsider | $215.00 | +14.2% |
| Morgan Stanley2026-07-23 · TheFly | $215.00 | +14.2% |
| UBS2026-07-02 · TheFly | $182.00 | -3.3% |
Source: aggregated sell-side analyst consensus · as of 2026-08-23. These are third-party analyst opinions — not CoinUnited’s view, not a price prediction, and not investment advice.
Scenario calculator
Pick a third-party reference level and see what it implies at leverage. Reference levels only - not a CoinUnited forecast.
Simplified: excludes fees, funding and slippage. Reference levels are third-party marks (CoinUnited daily kline; aggregated sell-side analyst targets), not forecasts. Leverage magnifies losses as much as gains - at high leverage a small adverse move liquidates the position. Not investment advice.
Catalysts & news
Catalyst Timeline
Dated third-party developments that move the stock — newest first, each classified bullish or bearish and linked to its source.
- 2026-10-21Next quarterly earnings◆ ScheduledNext scheduled quarterly earnings report (2026-10-21). Revenue, margins and guidance are the near-term driver; the outcome is not known in advance.Finnhub
- 2026-06-02PM lowers 2025 EPS guidance▼ BearishThe tobacco maker, which sells Marlboro cigarettes outside the US, now expects diluted earnings per share of $7.18 to $7.33, down from as much as $7.71, according to a statement Bloomberg Terminal Tuesday.
- 2026-06-02PM reduces 2026 EPS forecast▼ Bearish- Philip Morris now expects 2026 adjusted earnings per share of $8.31 to $8.46, a growth of 10.2% to 12.2% from 2025 levels, and lower than a prior forecast range of $8.36 to $8.51.
- 2026-04-22PM adjusts full year EPS range▼ BearishThe company anticipates adjusted earnings per share for the full year to be between $8.36 and $8.51, a decrease from its earlier of $.38 $853.
- 2025-02-06PM raises 2025 profit outlook▲ BullishOn February 6, Reuters reported that Philip Morris International (PM.N), a leading cigarette manufacturer, unveiled a more optimistic profit forecast for 2025 than anticipated, particularly for its rapidly expanding nicotine pouch brand…
- 2024-12-13PM settles flavored tobacco violation▼ BearishDec 13 (Reuters) - Tobacco powerhouse Philip Morris International (PM.N) has agreed to a $1.2 million settlement regarding an investigation into breaches of Washington D.C.'s prohibition on flavored tobacco products through its subsidiary…
Machine-readable table — same developments, with source
Recent third-party developments classified bullish / bearish for the stock; verbatim, sourced.
| Date | Development | Direction | Source |
|---|---|---|---|
| 2026-10-21 | Next scheduled quarterly earnings report (2026-10-21). Revenue, margins and guidance are the near-term driver; the outcome is not known in advance. | ◆ Scheduled | Finnhub |
| 2026-06-02 | The tobacco maker, which sells Marlboro cigarettes outside the US, now expects diluted earnings per share of $7.18 to $7.33, down from as much as $7.71, according to a statement Bloomberg Terminal Tuesday. | ▼ Bearish | Bloomberg |
| 2026-06-02 | - Philip Morris now expects 2026 adjusted earnings per share of $8.31 to $8.46, a growth of 10.2% to 12.2% from 2025 levels, and lower than a prior forecast range of $8.36 to $8.51. | ▼ Bearish | Reuters |
| 2026-04-22 | The company anticipates adjusted earnings per share for the full year to be between $8.36 and $8.51, a decrease from its earlier of $.38 $853. | ▼ Bearish | Reuters |
| 2025-02-06 | On February 6, Reuters reported that Philip Morris International (PM.N), a leading cigarette manufacturer, unveiled a more optimistic profit forecast for 2025 than anticipated, particularly for its rapidly expanding nicotine pouch brand… | ▲ Bullish | Reuters |
| 2024-12-13 | Dec 13 (Reuters) - Tobacco powerhouse Philip Morris International (PM.N) has agreed to a $1.2 million settlement regarding an investigation into breaches of Washington D.C.'s prohibition on flavored tobacco products through its subsidiary… | ▼ Bearish | Reuters |
Key Takeaways
Last updated: 2026-07-01- •FDA authorization for a PM smoke-free product is a rare regulatory milestone, directly de-risking the U.S. commercialization path for PM's next-generation pipeline.
- •PM trades at $180.56 with a 24h high of $183.11 — reclaiming that level is the near-term technical signal to watch for confirmation of bullish follow-through.
- •Stifel's reiteration (not upgrade) suggests the FDA event reinforces rather than transforms the bull case — investors should watch for PM management commentary on revenue impact.
- •Sector peers Altria and British American Tobacco may benefit from positive FDA sentiment spillover as they build their own smoke-free product portfolios.
- •PM's prior EPS guidance cut creates an overhang; this FDA catalyst alone is unlikely to reverse full-year estimates without additional smoke-free volume data.
Latest Pulses
Stifel Reiterates Buy on Philip Morris After FDA Authorization — What It Means for PM Stock
Stifel has reiterated its Buy rating on Philip Morris International following a U.S. Food and Drug Administration (FDA) authorization — a regulatory green light that represents a meaningful de-risking
Philip Morris Slashes Full-Year EPS Outlook: $500M Canada Impairment and Ruble Weakness Hit Hard
Philip Morris International (PM) has cut its full-year earnings per share guidance, citing two compounding headwinds: a ~$500 million impairment charge related to its Canadian operations and adverse f
Philip Morris Q2 2025 Earnings Beat: Smoke-Free Pivot Drives EPS and Revenue Surprise
Philip Morris International (PM) delivered a strong Q2 2025 earnings beat, with non-GAAP EPS of approximately $1.91–$1.96 surpassing consensus estimates by roughly $0.13, and revenue of $10.15B beatin
Ownership
Top Institutional Holders
SEC 13FThe largest institutional shareholders, from SEC Form 13F filings — who holds the stock and how much.
| Institution | Shares | Value | % of shares |
|---|---|---|---|
| Capital World Investors | 133.5M | $22.1B | 8.56% |
| BlackRock, Inc. | 107.5M | $17.8B | 6.90% |
| Vanguard Capital Management LLC | 101.2M | $16.7B | 6.49% |
| Capital Research Global Investors | 79.8M | $13.2B | 5.12% |
| Capital International Investors | 72.8M | $12.0B | 4.67% |
| State Street Corp. | 55.0M | $9.2B | 3.53% |
| JPMorgan Chase & Co. | 51.6M | $8.5B | 3.31% |
| GQG Partners LLC | 50.1M | $8.3B | 3.21% |
| FMR LLC | 44.8M | $7.4B | 2.87% |
| Geode Capital Management, LLC | 38.5M | $6.4B | 2.47% |
Source: SEC Form 13F filings · 2829 institutional holders · as of 31-MAR-2026. 13F data is quarterly and lagged (filed ~45 days after quarter-end) and covers US institutional managers (>$100M AUM) only — not insiders, retail, or foreign holders. Not investment advice.
How to trade it
Trading Regime Status
How the PM CFD works
Before you trade, understand exactly what you get, what you don't, and where the risk sits.
Price exposure to the PM reference (a synthetic CFD) that tracks the CoinUnited reference up and down.
It is not equity: no shares, no voting rights; dividends are reflected as an adjustment, not paid to you.
The CoinUnited reference tracks the share price but can differ from the exchange price; extended-hours liquidity is thinner.
Trading conditions on CoinUnited
Fee schedule as of 2026-08-19- Trading fee
- 0.070%
- Trading hours
- Market session
- Maximum leverage
- 800x
Per side, at the standard tier. Falls with 30-day volume and reaches 0.000% at VIP 9.
Follows the market session and is closed at weekends and on market holidays.
Availability and the maximum depend on product, jurisdiction and account eligibility. Leverage amplifies losses and positions can be liquidated.
Trading PM CFDs on CoinUnited.io
Philip Morris International is available on CoinUnited.io as a CFD instrument, a position that tracks the price of the underlying PM equity without conferring any shareholding, voting rights, or dividend entitlement. The position is purely directional price exposure, and all gains and losses are settled in cash terms relative to the entry price.
Instrument Structure and Leverage Mechanics
CoinUnited offers up to 800x leverage on the PM CFD. The mechanics are straightforward: margin multiplied by the leverage factor equals notional exposure. A 1% move in PM's underlying price then generates a profit or loss equal to 1% of that notional amount.
Worked example (hypothetical):
| Parameter | Value |
|---|---|
| Margin deposited | $100 |
| Leverage applied | 800x |
| Notional exposure | $80,000 |
| PM price moves +1% | +$800 P&L |
| PM price moves -1% | -$800 P&L |
| Return on margin (1% move) | ±800% |
This arithmetic is symmetric: leverage amplifies gains and losses in equal proportion. At 800x, a 0.125% adverse move against a fully margined position would approach full margin loss. Sizing relative to individual risk tolerance is the primary discipline when using high leverage on a single-stock CFD.
For traders building familiarity with earnings-driven positioning across large-cap equities, the Q2 Earnings Beat Blue-Chip Surge theme page provides relevant cross-sector context.
24/7 Access vs. NYSE Session Limits
PM shares list on the NYSE, which operates from 9:30 a.m. to 4:00 p.m. U.S. Eastern Time on trading days. Outside those hours, traditional equity investors cannot adjust positions. CoinUnited's PM CFD trades continuously, overnight, on weekends, and on U.S. public holidays, eliminating session gaps entirely.
This structural difference is most material around earnings. Adjusted diluted EPS came in at $2.20 for the quarter, above consensus estimates, with total net revenues of $11.2 billion reflecting 10.4% year-over-year growth. A traditional equity holder could not act on that print until the following morning's cash open.
A CoinUnited CFD trader could respond immediately, capturing the initial price discovery phase rather than receiving it as an opening gap.
This access advantage recurs every quarter and extends to any intraday macro event, central bank statements, geopolitical developments, or regulatory announcements, that affects PM outside standard market hours.
Zero-Fee Structure and Account Funding
CoinUnited charges zero trading fees on all PM CFD transactions. There are no commissions on entry or exit, no per-contract charges, and no spread markups in the fee structure. This is relevant for active traders who open and close positions frequently around catalysts, since fee drag compounds on short-duration trades.
Accounts are funded and withdrawn exclusively in crypto; no traditional bank account is required. This means onboarding does not depend on wire transfer infrastructure or banking relationships.
One cost to account for separately: overnight financing (cost of carry). This applies to leveraged CFD positions held across multiple days and accumulates proportionally to notional size. For traders holding PM CFDs through an earnings cycle or over a multi-week period, financing should be factored into the position economics alongside any expected price move.
PM-Specific Risks for CFD Traders
Several risk factors are specific to PM as a CFD underlying and warrant direct consideration.
Currency translation gaps. PM generates the majority of its revenues outside the United States. Reported growth and organic growth can diverge materially quarter to quarter depending on currency movements.
This differential can shift sharply in either direction and may affect how the market reads a headline revenue figure.
Earnings gap risk. Single-stock CFDs are exposed to overnight gaps around quarterly results. With high leverage, even a 2–3% gap at the open translates to a multiple of the margin in profit or loss.
If segment-level results diverge further from expectations, in either direction, the market reaction may not align with the headline total revenue number. Traders should monitor segment-level data in earnings releases, not just consolidated figures.
Regulatory event risk. PM's smoke-free growth trajectory depends in part on regulatory approvals for IQOS, ZYN, and other reduced-risk products in key markets. An adverse ruling or approval delay can produce an immediate price reaction independent of underlying financial performance.
The Consumer, Industrial & Energy Earnings Beat theme covers related dynamics across comparable consumer staples names.
Ready to Trade PM?
Up to 800x leverage
Understand the risks
Trading Risks
An honest, up-front list of the risks — both out of respect for the trader and as a YMYL compliance requirement.
High leverage means a small adverse move can trigger forced liquidation and loss of your full margin.
A high P/E stock is very sensitive to interest-rate and narrative shifts; swings can be large.
After-hours and weekend gaps; extended-hours liquidity is thinner than the regular session.
The CFD reference price can diverge from the exchange execution price.
Price swings widen around earnings dates and other scheduled disclosures.
Recalls, policy changes, or company-specific events can cause sharp moves.
Reference
Frequently Asked Questions
Philip Morris International sells tobacco and smoke-free products outside the United States, while Altria operates primarily within the U.S. domestic market. This structural split means PM and Altria hold largely non-overlapping geographic footprints, though they share the Marlboro brand in their respective territories. PM's international portfolio spans combustible cigarettes under established brand names as well as a growing lineup of smoke-free alternatives, most notably the IQOS heated tobacco system and Zyn nicotine pouches in certain markets. Because PM operates across many countries, its revenues are collected in a wide range of currencies and are subject to significant foreign exchange translation effects when reported in U.S. dollars. This international exposure shapes both the opportunity set and the risk profile of the business in ways that differ meaningfully from a purely domestic tobacco company.
Glossary
Key listed-stock and CFD terms, one line each — so the page is unambiguous for both readers and AI answer engines.
| Stock CFD | A contract for difference on a share price — price exposure only, not ownership of the underlying shares. |
|---|---|
| Extended hours | Pre-market and after-hours trading outside the exchange’s regular session. |
| Basis risk | The risk that the CFD reference price and the exchange execution price do not move in step. |
| P/E | Price-to-earnings ratio = share price ÷ earnings per share; a common valuation gauge. |
| Gross margin | Gross profit ÷ revenue; reflects product-level profitability. |
| EPS | Earnings per share = net income ÷ diluted shares outstanding. |
Tags
Source Map
Every figure on this page traces to a primary or named third-party source. "As of" dates the source; "last checked" dates our most recent read of it.
Every figure here is also published as machine-readable data, and re-checked on a schedule so a stale one shows up as stale. View the raw data
| Field | Value | Source | As of | Last checked | |
|---|---|---|---|---|---|
| Reference price | live | CoinUnited stock CFD reference (live) | — | — | — |
| Market cap | $293B | CoinUnited reference x SEC shares | 2026-08-23 | 2026-08-23 | — |
| P/E | ~25.9 | CoinUnited reference / SEC annual EPS | — | 2026-08-23 | — |
| 52-week range | $142.16 – $207.72 | CoinUnited daily kline | — | 2026-08-23 | — |
| Next earnings | 2026-10-21 | Finnhub | — | 2026-08-23 | — |
| Quarterly revenue | $11.19B | SEC 10-Q | Q2 2026 | 2026-08-23 | View |
| Net income | $2.82B | SEC 10-Q | Q2 2026 | 2026-08-23 | View |
| Gross margin | 68.4% | SEC 10-Q | Q2 2026 | 2026-08-23 | View |
| Diluted EPS | $1.80 | SEC 10-Q | Q2 2026 | 2026-08-23 | View |
| Institutional ownership | 10 top holders | SEC Form 13F | 31-MAR-2026 | 2026-08-23 | View |
| Analyst price targets | $210.50 consensus | Aggregated sell-side analyst consensus | 2026-08-23 | 2026-08-23 | — |
| Peer valuations | 6 peers | Third-party ratios (FMP), trailing twelve months | 2026-08-23 | 2026-08-23 | — |
| Founded | 2008 | Wikidata | — | 2026-08-23 | — |
| Headquarters | Lausanne, Stamford | Wikidata | — | 2026-08-23 | — |
| CEO | Hamish Maxwell | Wikidata | — | 2026-08-23 | — |
| Industry | tobacco industry, fast-moving consumer goods | Wikidata | — | 2026-08-23 | — |
| CoinUnited product | Stock CFD — price exposure, not equity (no voting; dividends reflected as adjustment); leverage available, extended/24h | CoinUnited product terms | — | 2026-08-23 | — |
Disclaimers & References
Important Risk Disclaimer
A CoinUnited stock CFD gives price exposure to Philip Morris International Inc only, not equity ownership: no shareholder voting rights, no dividends, and no settlement in the underlying share.
Leverage magnifies losses as well as gains, and a position can be liquidated long before the underlying share price recovers. The underlying listing trades on exchange hours, so the reference price can gap between sessions.
Users should conduct their own research and consult with qualified financial professionals before making any investment decisions. The creators and operators of this platform assume no responsibility for any financial losses or other damages that may result from reliance on the information provided.
Leveraged trading is extremely risky and you may lose your entire deposit.
Methodology Overview
Figures on this page are compiled from primary and named third-party sources, not produced by a forecasting model. Each one carries its source and date in the Source Map above.
- Financial statements: the company's own SEC filings (10-K / 10-Q), read from XBRL
- Market data: the CoinUnited reference price and daily closes
- Institutional ownership: SEC Form 13F quarterly filings
- Analyst targets: aggregated third-party sell-side coverage — third-party opinion, not CoinUnited's view
- Peer multiples: third-party trailing-twelve-month ratios
CoinUnited does not publish a price forecast or target for Philip Morris International Inc.
Last methodology review:
Ready to Start Trading Philip Morris International Inc?
Join thousands of traders and start your Philip Morris International Inc trading journey today. Get access to advanced trading tools and competitive fees.

PM
Philip Morris International Inc
Live from CoinUnited.io